MOH | Ticker Profile - Titan Protect

MOH

Molina Healthcare, Inc.

Healthcare · Healthcare Plans · NYQ

$190.86

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$9.3B

Total market value of the company

Trailing P/E

47.56

Expensive — high growth expected

Forward P/E

19.40

Based on estimated future earnings — lower means cheaper

Rev Growth

-4.3%

Year-over-year revenue change

Profit Margin

0.4%

How much profit the company keeps from each dollar of revenue

ROE

4.5%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$189.50

-1% from current price — median analyst estimate

Recommendation

HOLD

Consensus view from 16 analysts covering this stock

About Molina Healthcare, Inc.

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company was founded in 1980 and is headquartered in Long Beach, California.

https://www.molinahealthcare.com

Country: United States Employees: 19,000 Industry: Healthcare Plans

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

-0.270

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0278

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.378

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-25.0%

Historical annualised return based on price data

Max Drawdown

-66.0%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.85

Less volatile than the market — more defensive

52W High

$311.52

39% below the year high

52W Low

$121.06

58% above the year low

Avg Volume

1,456,355

Average daily shares traded — higher means easier to buy and sell

Short Ratio

2.2

Days it would take all short sellers to cover — higher means more crowded

Short % Float

6.5%

Moderate short interest

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$3.74

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

96.74

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.63

Healthy liquidity position

Quick Ratio

1.55

Like current ratio but excludes inventory — stricter test

Gross Margin

8.9%

Revenue left after cost of goods — higher means pricing power

Operating Margin

1.7%

Profit from core operations before interest and tax

Free Cash Flow

$758M

Positive — the business generates more cash than it spends

Revenue (TTM)

$43.1B

Total revenue over the last 12 months

Net Income

$188M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$262.00

Target Median

$189.50

Target Low

$129.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go